Cargando…
Scutellarin Alleviates Ischemic Brain Injury in the Acute Phase by Affecting the Activity of Neurotransmitters in Neurons
Cerebral ischemic stroke is a common neuron loss disease that is caused by the interruption of the blood supply to the brain. In order to enhance the CIS outcome, both identifying the treatment target of ischemic brain damage in the acute phase and developing effective therapies are urgently needed....
Autores principales: | Wang, Chunguo, Liu, Yaoyu, Liu, Xi, Zhang, Yuting, Yan, Xingli, Deng, Xinqi, Shi, Jinli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095904/ https://www.ncbi.nlm.nih.gov/pubmed/37049959 http://dx.doi.org/10.3390/molecules28073181 |
Ejemplares similares
-
Scutellarin protects oxygen/glucose-deprived astrocytes and reduces focal cerebral ischemic injury
por: Sun, Jing-Bo, et al.
Publicado: (2018) -
Scutellarin protects cortical neurons against neonatal hypoxic‐ischemic encephalopathy injury via upregulation of vascular endothelial growth factor
por: Zou, Yu, et al.
Publicado: (2022) -
PNS protects brain against ischemic injury by acting as an antagonist for AGE/RAGE signaling
por: Wang, Chunguo, et al.
Publicado: (2021) -
Scutellarin Reduce the Homocysteine Level and Alleviate Liver Injury in Type 2 Diabetes Model
por: Wang, Yiyu, et al.
Publicado: (2020) -
Comparative Metabolomic Analysis of the Neuroprotective Effects of Scutellarin and Scutellarein against Ischemic Insult
por: Tang, Hao, et al.
Publicado: (2015)